How do you want your Singulair be delivered? Choose here!

* Company Posts Third-Quarter Earnings Per Share (EPS) of 51 Cents, Including the Impact of Reserving an Additional $598 Million Solely for Future VIOXX Legal Defense Costs and Excluding Restructuring Charges; Reported Third-Quarter EPS of 43 Cents
* VYTORIN and ZETIA Achieve Combined Global Sales of More Than $1 Billion in the Third Quarter
* Vaccine Sales Growth Strong; GARDASIL Reached $70 Million in the Third Quarter
* Merck Raises Full-Year 2006 Guidance and Now Anti…

Merck & Co. Inc. said yesterday that its quarterly profit doubled over the last year and should keep rising as it slashes costs and pursues deals with 40 companies to develop new drugs.
The results were powered in part by stronger-than-expected sales of Merck’s asthma drug Singulair and its cholesterol medicine Vytorin, which Merck is co-marketing with Schering-Plough Corp. Vytorin revenue nearly doubled to $973 million in the second quarter from $507 million a year earlier, even as Merc…

The global respiratory drug market is projected to exceed sales of $44 billion by 2010, according to market research firm Kalorama Information.
As the incidence of lung and breathing-related illnesses climb around the world, drug sales in the segment have continued to rise as well. Kalorama researchers report that sales have increased a…

MERCK’S STUDY of how consumers process information from television advertisements is underway-and initial testing suggests the firm’s protocol can pick up discrepancies between ads, said Ed Slaughter of Merck’s Commercial Model Group.
Merck drafted Omnicom’s DDB and WPP’s Ogilvy Healthworld to design multiple versions of ads for use in t…

Denver, CO - LegalView, the number one resource for everything legal on the Internet, informed mesothelioma blog readers of the preexisting dangers that can be associated with removing or disposing of debris that is left in the wake of natural disasters like storms and tornadoes. Victims in Kansas, who recently suffered from a series of severe storms, were left with massive amounts of debris in areas of the state that coul…

Increlex

(mecasermin [rDNA origin] injection, Tercica Inc.)

The Food and Drug Administration approved Increlex for long-term treatment of growth failure in children 2 years or older with severe primary insulinlike growth factor-1 (IGF-1) deficiency or with growth hormone gene deletion.

* Recommended dosage: Starting dose is 0.04-0.08 mg/kg twice daily…

Denver, CO - LegalView, the most comprehensive legal portal on the Web, recently announced the launch of its http://pagcl-pain-pump.legalview.com[post arthroscopic glenohumeral chondrolysis __title__ PAGCL] (PAGCL) practice area PAGCL is a severe and painful condition where shoulder cartilage begins to deteriorate and can affect many Americans after arthroscopic shoulder surgery. The condition’s cause remains unclear but has been frequently linked to patients who have previously undergone shou…

Merck & Co. Inc. is coming back.
Two years ago, the company was reeling from its failed pain reliever, Vioxx, and from the impending loss of one of its most profitable drugs. Analysts were openly skeptical about the company's prospects.
But yesterday, Merck reported a 62 percent rise in net income for the third quarter, fueled by a doubling…

* Evidence summary
It is difficult to interpret studies on exercise-induced bronchoconstriction (the rather uncommon presence of exerciseinduced bronchospasm in a nonasthmatic) and exercise-induced asthma (the more common situation of asthma worsened by exercise). Many studies inclu…